Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
5.03
-0.10 (-1.95%)
At close: Nov 22, 2024, 4:00 PM
5.29
+0.26 (5.13%)
After-hours: Nov 22, 2024, 6:06 PM EST
Outlook Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$48.20
Upside
+858.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +894.04% | Oct 18, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +556.06% | Sep 3, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $53 | Strong Buy | Maintains | $53 | +953.68% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +496.42% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +496.42% | May 17, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +894.04% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +496.42% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +1,092.84% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +695.23% | Jan 25, 2024 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $31 | Hold → Strong Buy | Upgrades | $31 | +524.25% | Jan 25, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $30 → $40 | Strong Buy | Maintains | $30 → $40 | +695.23% | Dec 29, 2023 |
| Capital One | Capital One | Hold → Buy Upgrades $100 | Hold → Buy | Upgrades | $100 | +1,888.07% | Dec 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $40 | Strong Buy | Maintains | $20 → $40 | +695.23% | Nov 3, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $20 | Strong Buy → Hold | Downgrades | $20 | +297.61% | Aug 31, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 30, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.